In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 1: Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
Session

Congress : Acute Cardiovascular Care 2019

Topic : Other

  • Session type : Poster Session
  • Date : 02 March 2019
  • Time : 09:00 - 17:30

16 presentations in this session

Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention - Poster discussant - 12:45 - 13:45.

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention

A novel high-sensitivity cardiac troponin i assay for early diagnosis of acute myocardial infarction

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : J Boeddinghaus (Basel,CH)

miR-1 and miR-126 concentrations in patients with acute myocardial infarction ?treated invasively.

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : E Kazimierczyk (Bialystok,PL)

Without rhyme or reason...are we abusing of troponin testing?

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : J Bonello (Santa Lucia,MT)

Prognostic value of high sensitivity troponin T second peak occurrence after ST elevation myocardial infarction

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : ABN Pinto Gomes (Lisboa,PT)

Early p2y12 inhibitors escalation in st segment elevation myocardial infarction: prevalence, impact on platelet production and function, and long-term prognosis

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : L Malinova (Saratov,RU)

Early versus delayed treatment with ticagrelor on residual thrombus after percutaneous coronary intervention in patients presenting with non-ST-elevation acute coronary syndrome

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : JM Cho (Seoul,KR)

Clinical parameters associated with ST segment resolution 60 minutes after fibrinolytic in STEMI patients

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : T Daindes (Padang,ID)

Polymorphism rs776746 in the gene of cyp3a5 is able to us for predicting of clinical efficiency of bisoprolol in patients with acute coronary syndromec

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Efficacy and safety of association of abciximab with prasugrel or ticagrelor in patients undergoing percutaneous intervention.

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : C Fernandez Diaz (Valencia,ES)

Prognosis of arterial thromboembolic complications in patients with extrasystolic arrhythmia

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : O Germanova (Samara,RU)

Degrees in the coronary flow impairment related to therapy and diastolic dysfunction in patients with non-obstructive coronary artery disease

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : N Semerdzieva (Sofia,BG)

The Utilisation of predischarge checklist for effective patient communication in acute coronary syndrome patients.

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : S Quek (Bradford,GB)

Which canc prevent cardiac remodelling in high risk patients, control of hypertension or control of diabetes?

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : M El Tahlawi (Zagazig,EG)

Association of the vasoactive therapy with impairment in coronary flow and persistence of angina in patients with non-obstructive coronary disease and slow coronary flow

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : N Semerdzieva (Sofia,BG)

Improvement of lipid profile post cardiac rehabilitation in patients with previous ACS according to the patient's level of risk

Congress : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : A Chauca Tapia (Cadiz,ES)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are